4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001193125-26-170468
Options or other derivatives
- Director bought 2,252,252 shares at $4.44 ($9,999,774)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2026-04-21 | Purchase · Warrants to purchase Common Stock | +114,601 | $4.44 | $508,817 | 1,678,273 | I |
| BAKER BROS. ADVISORS LP Director | 2026-04-21 | Purchase · Warrants to purchase Common Stock | +2,137,651 | $4.44 | $9,490,957 | 20,105,994 | I |
Loading xslF345X06/ownership.xml…